华纳药厂(688799.SH)：富马酸福莫特罗吸入溶液获药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the drug registration certificate of Formoterol Fumarate Inhalation Solution, which is intended for the maintenance treatment of bronchial constriction in patients with Chronic Obstructive Pulmonary Disease (COPD) [1] Group 1 - The Formoterol Fumarate Inhalation Solution is specifically used for patients with COPD, including chronic bronchitis and emphysema [1] - The medication is to be administered twice daily, in the morning and evening, and can be used for long-term treatment [1]